問卷

TPIDB > 臨床試驗主持人

臨床試驗主持人


長庚醫療財團法人林口長庚紀念醫院 (在職)

血液腫瘤科

放射腫瘤科

內科

消化內科

放射診斷科

外科

更新時間:2023-09-19

謝佳訓Hsieh, Chia-Hsun
  • 計畫主持人
  • 執行臨床試驗年資 12 年 9 個月
  • wisdom5000@cgmh.org.tw

發表文獻

65

41

Tzu-Keng Chiu, Wen-Pin Chou, Song-Bin Huang, Hung-Ming Wang, Yung-Chang Lin, Min-Hsien Wu*, Chia-Hsun Hsieh* (通訊作者) “Application of optically-induced-dielectrophoresis in microfluidic system for purification of circulating tumour cells for gene expression analysis- Cancer cell line model”. Scientific Reports. 2016 Sep 9;6:32851. doi: 10.1038/srep32851.

42

Po-Jung Su, Min-Hsien Wu, Hung-Ming Wang, Chia-Lin Lee, Wen-Kuan Huang, Chiao-En Wu, Hsien-Kun Chang, Yin-Kai Chao, Chen-Kan Tseng, Tzu-Keng Chiu, Nina Ming-Jung Lin, Siou-Ru Ye, Jane Ying-Chieh Lee, Chia-Hsun Hsieh*(通訊作者) “Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy ” Scientific Reports. 2016 Aug 17;6:31423. doi: 10.1038/srep31423.

43

W.K. Huang, T.T. Kuo, C.E. Wu, H.Y. Cheng, Chia-Hsun Hsieh, J.J. Hsieh, Y.C. Shen, M.M. Hou, T. Hsu, J.W. Chang* ”A comparison of immunohistochemical and molecular methods used for analyzing the BRAF V600E gene mutation in malignant melanoma in Taiwan”. Asia-Pacific Journal of Clinical Oncology. 2016 Dec;12(4):403-408. doi: 10.1111/ajco.12574. Epub 2016 Aug 4.

44

Hung-Ming Wang, Chun-Ta Liao, Tzu-Chen Yen, Shu-Jen Chen, Li-Yu Lee, Chia-Hsun Heish, Chien-Yu Lin, and Shu-Hang Ng* "Clues toward precision medicine in oral cavity squamous cell carcinoma: utility of next-generation sequencing for the prognostic stratification of high-risk patients harboring neck lymph node extracapsular extension" Oncotarget. 2016 Sep 27;7(39):63082-63092. doi: 10.18632/oncotarget.11762.Oncotarget

45

Pei-Yu Hsu, Sien Hung Yang, Ngan Ming Tsang, Kang-Hsing Fan, Chia-Hsun Hsieh, Jr-Rung Lin, Ji Hong Hong, Yung Chang Lin, Hsing-Yu Chen, Cheng-Tao Yang, Ching-Wei Yang and Jiun-Liang Chen* “Efficacy of Traditional Chinese Medicine in Xerostomia and Quality of Life During Radiotherapy for Head and Neck Cancer: A Prospective Pilot Study.” Evidence-Based Complementary and Alternative Medicine. 2016;2016:8359251. doi: 10.1155/2016/8359251. Epub 2016 Aug 21.

46

Pei-Hung Chang, Kun-Yun Yeh, Cheng-Hsu Wang, Eric Yen-Chao Chen, Shih-Wei Yang, Wen-Chi Chou, Jason Chia-Hsun Hsieh*(通訊作者) “Impact of metformin on advanced head and neck cancer patients undergoing concurrent chemoradiotherapy.” HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 2017 Aug;39(8):1573-1577. doi: 10.1002/hed.24793. Epub 2017 Apr 27.

47

Yap, Wing-Keen, Chang, Yu-Chuan, Tseng, Chen-Kan, Hsieh, Chia-Hsun, Chao, Yin-Kai, Su, Po-Jung, Hou, Ming-Mo, Yang, Chan-Keng, Pai, Ping-Ching, Lin, Ching-Rong, Hsieh, Cheng-En, Wu, Yao-Yu, Hung, Tsung-Min* “Predictive Value of Nodal SUVmax of Pretreatment FDG-PET Imaging in Patients with Esophageal Cancer”. DISEASES OF THE ESOPHAGUS. 2017 Aug 1;30(8):1-10. doi: 10.1093/dote/dox021.

48

WC Chou, CL Lee, TS Yang, CY Huang, W Teng, YT Tseng, JS Chen, YC Lin, MM Hou, HH Chang, Jason CH Hsieh*(通訊作者) “Changes in the Serum α-Fetoprotein Level Predict Treatment Response and Survival in Hepatocellular Carcinoma Patients and Literature Review”. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION. 2018 Feb;117(2):153-163. doi: 10.1016/j.jfma.2017.03.010. Epub 2017 Apr 6.

49

Chia-Jung Liao, Chia-Hsun Hsieh(共同第一作者), Hung-Ming Wang, Wen-Pin Chou, Tzu-Keng Chiu, Jyun-Huan Chang, A.-Ching Chao* and Min-Hsien Wu* ” Isolation of label-free and viable circulating tumour cells (CTCs) from blood samples of cancer patients through a two-step process: negative selection-type immunomagnetic beads and spheroid cell culture-based cell isolation” RSC Advances, Issue 47, 2017,DOI 10.1039/C7RA03663A Issue in Progress.

50

Chan SC, Cheng NM, Hsieh Chia-Hsun, Ng SH, Lin CY, Yen TC, Hsu CL, Wan HM, Liao CT, Chang KP, Wang JJ* ”Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy” Oncotarget. 2017 Mar 4;8(37):62606-62621. doi: 10.18632/oncotarget.15904. eCollection 2017 Sep 22.